Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma (Q39249967)

10 September 2017

Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma (English)

1 reference

10 September 2017

1 reference

3

Andrew V Schally

1 reference

10 September 2017

Manuel Sánchez-Chapado

series ordinal

4

object named as

Manuel Sánchez-Chapado

1 reference

10 September 2017

1

Eva Vacas

1 reference

10 September 2017

Ana M Bajo

2

1 reference

10 September 2017

Juan C Prieto

series ordinal

5

1 reference

10 September 2017

María J Carmena

series ordinal

6

1 reference

10 September 2017

language of work or name

1 reference

1 November 2012

1 reference

Molecular and Cellular Endocrinology

10 September 2017

1 reference

10 September 2017

365

1 reference

10 September 2017

2

1 reference

10 September 2017

212-222

1 reference

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion

10 September 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Molecular diagnosis and therapy of kidney cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Renal oxygenation suppresses VHL loss-induced senescence that is caused by increased sensitivity to oxidative stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Role of VHL gene mutation in human cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Novel aspect of chemophototherapy in treatment of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

The metastatic cascade in prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Molecular basis of the VHL hereditary cancer syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Oxygen sensing by HIF hydroxylases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Signaling pathways in renal cell carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Dissemination and growth of cancer cells in metastatic sites

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Cadherins in development: cell adhesion, sorting, and tissue morphogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Cellular redox pathways as a therapeutic target in the treatment of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Intercellular adhesion, signalling and the cytoskeleton

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Redox control of the cell cycle in health and disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

2009 update on the classification of renal epithelial tumors in adults

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Resistance to targeted therapy in renal-cell carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Basic research in kidney cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

The epidemiology of renal cell carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.MCE.2012.10.021

Identifiers

DOI

10.1016/J.MCE.2012.10.021

1 reference

release_4vwfaec73vhahicnwnyl25kfue

10 September 2017

0 references

1 reference